Filing Flows › Bruker (BRKR) › Q3 2026 › vs Q3 2025
Bruker (BRKR) Q3 2026 vs Q3 2025 (year over year)
Bruker's revenue rose $13.5M (+2%) from $860M in Q3 2025 to $874M in Q3 2026. The biggest changes: Energy and Supercon Technologies +$7.5M (+10%); BSIBIOS +$6.0M (+2%); Bsi Nano −$3.4M (-1%).
Bruker, Q3 2026: revenue $874M (+2% year over year), operating margin -10.4%, net loss $110M, operating cash flow $118M. The chart draws each line against Q3 2025, the increases inside each band.
Every line
| Line | Q3 2026 | Q3 2025 | Change | % |
|---|---|---|---|---|
| BSIBIOS | $397M | $391M | $6.0M | +2% |
| Bsi Nano | $263M | $266M | −$3.4M | -1% |
| BSIBMID | $134M | $130M | $3.4M | +3% |
| Energy and Supercon Technologies | $80.1M | $72.6M | $7.5M | +10% |
| Revenue | $874M | $860M | $13.5M | +2% |
| Income tax benefit | $12.2M | $14.1M | −$1.9M | -13% |
| Net loss | $110M | $58.5M | $51.2M | +88% |
| Costs & expenses | $996M | $933M | $62.8M | +7% |
| Operating costs | $965M | $912M | $52.7M | +6% |
| Interest & other, net | $30.9M | $20.8M | $10.1M | +49% |
| Cost of revenue | $445M | $481M | −$36.4M | -8% |
| Research & development | $92.0M | $98.3M | −$6.3M | -6% |
| SG&A | $226M | $242M | −$16.0M | -7% |
| Other operating costs | $202M | $90.4M | $111M | +123% |
| Operating cash sources | $228M | $25.3M | $203M | +801% |
| Depreciation & amortization | $54.1M | $55.7M | −$1.6M | -3% |
| Share-based compensation | $6.1M | $6.0M | $100K | +2% |
| Working capital & other | $168M | −$36.4M | $204M | — |
| Net loss absorbed | $110M | $58.5M | $51.2M | +88% |
| Operating cash flow | $118M | −$33.2M | $151M | — |
Questions
How much did Bruker's revenue grow year over year in Q3 2026?
Bruker's revenue rose $13.5M (+2%) from $860M in Q3 2025 to $874M in Q3 2026.
What drove Bruker's revenue change in Q3 2026?
Energy and Supercon Technologies +$7.5M (+10%); BSIBIOS +$6.0M (+2%); Bsi Nano −$3.4M (-1%).